NEW

Butterfly Files Motion to Dismiss Claims in FUJIFILM Sonosite Legal Action

Butterfly Network Inc. has filed a motion to dismiss claims and specific patents from a complaint for patent infringement lawsuit filed on March 9, 2022, by FUJIFILM Sonosite Inc. Butterfly believes the lawsuit alleging infringement of U.S. Patent Nos. 7,169,108;...

ARTIS icono ceiling Angiography System Earns FDA Clearance

Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology. The...

New Fixed X-ray System Brings ‘Personal Assistant’ to Radiology Departments

GE Healthcare released its most advanced fixed X-ray system yet, the next-generation Definium 656 HD. Leading GE Healthcare’s portfolio of fixed X-ray products, this latest generation of the overhead tube suspension (OTS) system delivers consistent, highly automated,...

Exo Acquires Medo AI

Exo (pronounced “echo”), a pioneering health information and medical devices company, has announced that it is acquiring Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use. By integrating Medo’s...

NKV-330 Ventilator System Receives FDA 510(k) Clearance

Nihon Kohden OrangeMed Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its NKV-330 Ventilator System. The NKV-330 is a non-invasive ventilator that provides respiratory support to adult and pediatric patients. This system offers invasive and non-invasive ventilation, as well as high flow oxygen therapy. In addition, it provides continuous monitoring of CO2 when using the cap-ONE NIV mask. The cap-ONE mask is an NIV interface that allows quality CO2 monitoring directly from the ventilator.

“The NKV-330 ventilator can help hospitals who face a limited choice of new non-invasive ventilator platforms for adult and pediatric patients,” said Eiichi Tanaka, president and CEO of Nihon Kohden America. “This new platform offers a seamless transition between non-invasive therapy and high flow oxygen therapy to meet the changing needs of patients. The continuous monitoring of ETCO2, the excellent portability, dual HEPA filtration, ‘hot-swap’ battery, and many other features in the NKV-330 makes it a great choice for hospitals and health care providers.”

The NKV-330 Ventilator System is distributed in the United States by Nihon Kohden America Inc. and is expected to begin shipping in July 2022. It has been available outside of the United States since 2019.

For more information, visit Orange-Med.com.

Previous

Next

Submit a Comment

Your email address will not be published.